Copyright Reports & Markets. All rights reserved.

Global Infection Prevention and Enteral Access Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Infection Prevention and Enteral Access Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Infection Prevention and Enteral Access Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Infection Prevention and Enteral Access Market Size Growth Rate by Type
    • 1.4.2 Enteral Feeding Pumps
    • 1.4.3 Enteral Feeding Tubes
    • 1.4.4 Administration Reservoirs
    • 1.4.5 Giving Sets
    • 1.4.6 Enteral Syringes
  • 1.5 Market by Application
    • 1.5.1 Global Infection Prevention and Enteral Access Market Size Growth Rate by Application
    • 1.5.2 Oncology
    • 1.5.3 Gastroenterology
    • 1.5.4 Diabetes
    • 1.5.5 Neurological Disorders
    • 1.5.6 Hypermetabolism
    • 1.5.7 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Infection Prevention and Enteral Access Market Size, Estimates and Forecasts
    • 2.1.1 Global Infection Prevention and Enteral Access Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Infection Prevention and Enteral Access Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Infection Prevention and Enteral Access Production Estimates and Forecasts 2015-2026
  • 2.2 Global Infection Prevention and Enteral Access, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Infection Prevention and Enteral Access Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Infection Prevention and Enteral Access Manufacturers Geographical Distribution
  • 2.4 Key Trends for Infection Prevention and Enteral Access Markets & Products
  • 2.5 Primary Interviews with Key Infection Prevention and Enteral Access Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Infection Prevention and Enteral Access Manufacturers by Production Capacity
    • 3.1.1 Global Top Infection Prevention and Enteral Access Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Infection Prevention and Enteral Access Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Infection Prevention and Enteral Access Manufacturers Market Share by Production
  • 3.2 Global Top Infection Prevention and Enteral Access Manufacturers by Revenue
    • 3.2.1 Global Top Infection Prevention and Enteral Access Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Infection Prevention and Enteral Access Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Infection Prevention and Enteral Access Revenue in 2019
  • 3.3 Global Infection Prevention and Enteral Access Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Infection Prevention and Enteral Access Production by Regions

  • 4.1 Global Infection Prevention and Enteral Access Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Infection Prevention and Enteral Access Regions by Production (2015-2020)
    • 4.1.2 Global Top Infection Prevention and Enteral Access Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Infection Prevention and Enteral Access Production (2015-2020)
    • 4.2.2 North America Infection Prevention and Enteral Access Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Infection Prevention and Enteral Access Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Infection Prevention and Enteral Access Production (2015-2020)
    • 4.3.2 Europe Infection Prevention and Enteral Access Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Infection Prevention and Enteral Access Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Infection Prevention and Enteral Access Production (2015-2020)
    • 4.4.2 China Infection Prevention and Enteral Access Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Infection Prevention and Enteral Access Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Infection Prevention and Enteral Access Production (2015-2020)
    • 4.5.2 Japan Infection Prevention and Enteral Access Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Infection Prevention and Enteral Access Import & Export (2015-2020)

5 Infection Prevention and Enteral Access Consumption by Region

  • 5.1 Global Top Infection Prevention and Enteral Access Regions by Consumption
    • 5.1.1 Global Top Infection Prevention and Enteral Access Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Infection Prevention and Enteral Access Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Infection Prevention and Enteral Access Consumption by Application
    • 5.2.2 North America Infection Prevention and Enteral Access Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Infection Prevention and Enteral Access Consumption by Application
    • 5.3.2 Europe Infection Prevention and Enteral Access Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Infection Prevention and Enteral Access Consumption by Application
    • 5.4.2 Asia Pacific Infection Prevention and Enteral Access Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Infection Prevention and Enteral Access Consumption by Application
    • 5.5.2 Central & South America Infection Prevention and Enteral Access Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Infection Prevention and Enteral Access Consumption by Application
    • 5.6.2 Middle East and Africa Infection Prevention and Enteral Access Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Infection Prevention and Enteral Access Market Size by Type (2015-2020)
    • 6.1.1 Global Infection Prevention and Enteral Access Production by Type (2015-2020)
    • 6.1.2 Global Infection Prevention and Enteral Access Revenue by Type (2015-2020)
    • 6.1.3 Infection Prevention and Enteral Access Price by Type (2015-2020)
  • 6.2 Global Infection Prevention and Enteral Access Market Forecast by Type (2021-2026)
    • 6.2.1 Global Infection Prevention and Enteral Access Production Forecast by Type (2021-2026)
    • 6.2.2 Global Infection Prevention and Enteral Access Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Infection Prevention and Enteral Access Price Forecast by Type (2021-2026)
  • 6.3 Global Infection Prevention and Enteral Access Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Infection Prevention and Enteral Access Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Infection Prevention and Enteral Access Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Cook Medical
    • 8.1.1 Cook Medical Corporation Information
    • 8.1.2 Cook Medical Overview
    • 8.1.3 Cook Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Cook Medical Product Description
    • 8.1.5 Cook Medical Related Developments
  • 8.2 Medtronic plc
    • 8.2.1 Medtronic plc Corporation Information
    • 8.2.2 Medtronic plc Overview
    • 8.2.3 Medtronic plc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Medtronic plc Product Description
    • 8.2.5 Medtronic plc Related Developments
  • 8.3 Boston Scientific Corporation
    • 8.3.1 Boston Scientific Corporation Corporation Information
    • 8.3.2 Boston Scientific Corporation Overview
    • 8.3.3 Boston Scientific Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Boston Scientific Corporation Product Description
    • 8.3.5 Boston Scientific Corporation Related Developments
  • 8.4 CONMED Corporation
    • 8.4.1 CONMED Corporation Corporation Information
    • 8.4.2 CONMED Corporation Overview
    • 8.4.3 CONMED Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 CONMED Corporation Product Description
    • 8.4.5 CONMED Corporation Related Developments
  • 8.5 CORPAK MedSystems
    • 8.5.1 CORPAK MedSystems Corporation Information
    • 8.5.2 CORPAK MedSystems Overview
    • 8.5.3 CORPAK MedSystems Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 CORPAK MedSystems Product Description
    • 8.5.5 CORPAK MedSystems Related Developments
  • 8.6 CR Bard
    • 8.6.1 CR Bard Corporation Information
    • 8.6.2 CR Bard Overview
    • 8.6.3 CR Bard Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 CR Bard Product Description
    • 8.6.5 CR Bard Related Developments
  • 8.7 ALCOR Scientific
    • 8.7.1 ALCOR Scientific Corporation Information
    • 8.7.2 ALCOR Scientific Overview
    • 8.7.3 ALCOR Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 ALCOR Scientific Product Description
    • 8.7.5 ALCOR Scientific Related Developments
  • 8.8 Pacific Hospital Supply
    • 8.8.1 Pacific Hospital Supply Corporation Information
    • 8.8.2 Pacific Hospital Supply Overview
    • 8.8.3 Pacific Hospital Supply Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Pacific Hospital Supply Product Description
    • 8.8.5 Pacific Hospital Supply Related Developments
  • 8.9 Teleflexorporated
    • 8.9.1 Teleflexorporated Corporation Information
    • 8.9.2 Teleflexorporated Overview
    • 8.9.3 Teleflexorporated Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Teleflexorporated Product Description
    • 8.9.5 Teleflexorporated Related Developments
  • 8.10 Vygon SA
    • 8.10.1 Vygon SA Corporation Information
    • 8.10.2 Vygon SA Overview
    • 8.10.3 Vygon SA Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 Vygon SA Product Description
    • 8.10.5 Vygon SA Related Developments

9 Infection Prevention and Enteral Access Production Forecast by Regions

  • 9.1 Global Top Infection Prevention and Enteral Access Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Infection Prevention and Enteral Access Regions Forecast by Production (2021-2026)
  • 9.3 Key Infection Prevention and Enteral Access Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Infection Prevention and Enteral Access Consumption Forecast by Region

  • 10.1 Global Infection Prevention and Enteral Access Consumption Forecast by Region (2021-2026)
  • 10.2 North America Infection Prevention and Enteral Access Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Infection Prevention and Enteral Access Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Infection Prevention and Enteral Access Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Infection Prevention and Enteral Access Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Infection Prevention and Enteral Access Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Infection Prevention and Enteral Access Sales Channels
    • 11.2.2 Infection Prevention and Enteral Access Distributors
  • 11.3 Infection Prevention and Enteral Access Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Infection Prevention and Enteral Access Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 Infection Prevention and Enteral Access Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Infection Prevention and Enteral Access Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Infection Prevention and Enteral Access market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infection Prevention and Enteral Access market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Infection Prevention and Enteral Access market is segmented into
    Enteral Feeding Pumps
    Enteral Feeding Tubes
    Administration Reservoirs
    Giving Sets
    Enteral Syringes

    Segment by Application, the Infection Prevention and Enteral Access market is segmented into
    Oncology
    Gastroenterology
    Diabetes
    Neurological Disorders
    Hypermetabolism
    Others

    Regional and Country-level Analysis
    The Infection Prevention and Enteral Access market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Infection Prevention and Enteral Access market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
    Competitive Landscape and Infection Prevention and Enteral Access Market Share Analysis

    Infection Prevention and Enteral Access market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Infection Prevention and Enteral Access by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Infection Prevention and Enteral Access business, the date to enter into the Infection Prevention and Enteral Access market, Infection Prevention and Enteral Access product introduction, recent developments, etc.
    The major vendors covered:
    Cook Medical
    Medtronic plc
    Boston Scientific Corporation
    CONMED Corporation
    CORPAK MedSystems
    CR Bard
    ALCOR Scientific
    Pacific Hospital Supply
    Teleflexorporated
    Vygon SA

    Buy now